Showing results (21-30 of 208) with videos related to
Sort By:
Pageof 21
Current Opinion in Cardiology|September 12, 2022
Is the world ready for the STICH 3.0 trial?Dominique Vervoort, Marc E Jolicoeur, Guillaume Marquis-Gravel, et al.The Annals of Thoracic Surgery|May 7, 2018
Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk PatientsDerrick Y Tam, Avery Hughes, Harindra C Wijeysundera, et al.Current Opinion in Cardiology|April 12, 2024
No-touch saphenous vein: current understanding of the conduit 'less handled'Mimi X Deng, Grace S Lee, Dominique Vervoort, et al.The New England Journal of Medicine|November 27, 2004
A randomized comparison of radial-artery and saphenous-vein coronary bypass graftsNimesh D Desai, Eric A Cohen, C David Naylor, et al.Circulation|July 6, 2006
Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trialsVeena Guru, John Omura, Abdullah A Alghamdi, et al.JTCVS Open|May 1, 2025
Graft patency of no-touch versus conventionally harvested saphenous vein conduits in coronary artery bypass grafting: A frequentist and Bayesian meta-analysis of randomized trialsMimi X Deng, Zhenyu Li, Dominique Vervoort, et al.CJC Open|September 2, 2025
Win Ratio in Biomedical Science: A Bibliometric AnalysisZhenyu Li, Aliya Izumi, Dominique Vervoort, et al.BMC Medical Research Methodology|November 21, 2021
On clinical trial fragility due to patients lost to follow upBenjamin R Baer, Stephen E Fremes, Mario Gaudino, et al.The Canadian Journal of Cardiology|January 17, 2009
Publicly reported provider outcomes: the concerns of cardiac surgeons in a single-payer systemVeena Guru, C David Naylor, Stephen E Fremes, et al.Journal of Clinical Epidemiology|August 17, 2021
The fragility index can be used for sample size calculations in clinical trialsBenjamin R Baer, Mario Gaudino, Stephen E Fremes, et al.Pageof 21